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Received August 20, 2015; accepted February 26, 2016AbstractBackground: Mixed epithelial and stromal tumor of the kidney (MESTK) is a rare tumor, with few malignant cases reported. Occurring mostly in
middle-aged women, it is characterized by a biphasic pathological structure.
Methods: This study retrospectively reviewed the imaging findings and medical records of six MESTK cases of a single institution in a 10-year
period.
Results: All of the patients were middle-aged women without hormone therapy history. The typical image was a renal tumor with varied cystic
components. Half of the cases had sinus invagination, but only one had intratumor calcification. On imaging studies, four were Bosniak Category
IV, one was Category III, and one presented as a solid tumor. The mean RENAL nephrometry score was 9.3. Five patients underwent partial
nephrectomy, with no statistical renal functional deterioration after nephron-sparing surgery. There were no peri-operative complications.
Conclusion: Surgery remains the treatment of choice for MESTK, and nephron-sparing surgery should be considered in feasible cases.
Copyright © 2016, the Chinese Medical Association. Published by Elsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Mixed epithelial and stromal tumor of the kidney (MESTK)
is a rare neoplasm. The first case was described in 1998 by
Michal and Syrucek.1 Histopathologically, it is composed of
epithelial and stromal components, thereby appearing as a
cystic renal mass with varying proportions of solidConflicts of interest: The authors declare that they have no conflicts of interest
related to the subject matter or materials discussed in this article.
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license (http://creativecommons.org/licenses/by-nc-nd/4.0/).components on imaging. Until 2010, approximately 150 cases
had been reported,2 although most reports focused on the
pathologic and radiographic features.3e5 However, preopera-
tive diagnosis of MESTK is problematic, since most of these
tumors are Bosniak Category IV or solid lesions. Therefore
most cases are treated surgically.4 This is a retrospective
analysis of six cases of MESTK with detailed imaging pro-
files, treatment decision-making, and clinical outcomes.
2. Methods
Between March 2004 and November 2013, there were six
cases of MESTK diagnosed histopathologically in a single
institution. We followed the provisions of the Declaration ofsevier Taiwan LLC. This is an open access article under the CC BY-NC-ND
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Patients' demographic data (i.e., age, sex, and menopausal
status), laterality of the mass, hormone replacement, clinical
symptoms, imaging findings, and peri-operative outcomes
were reviewed.
Noncontrast and contrast-enhanced computed tomography
(CT) before surgery were performed. The CT imaging
included the largest diameter of the renal tumor, proportion of
cystic component, calcification status, contrast enhancement,
sinus invagination, septum, Bosniak category,6 and RENAL
nephrometry score.7
The peri-operative outcome variables assessed were surgi-
cal technique, estimated blood loss, operative time, ischemia
time for partial nephrectomy, complications, and recurrence.
Serum creatinine was checked preoperatively and at 3-months
postoperatively. Measurement of effective renal plasma flow
(ERPF) using scintigraphy with I-131-orthoiodohippurate was
also done preoperatively and at 3e6-months postoperatively.
The estimated glomerular filtration rate (eGFR) was calculated
with the Modification of Diet in Renal Disease equation. The
split renal function for the five patients who underwent partial
nephrectomy was calculated as the percentage of ERPF of the
diseased kidney divided by the total ERPF. Differences in
renal function preoperatively and postoperatively were evalu-
ated using Student t test for continuous variables.
3. Results
Based on the demographic parameters, all of the patients
were female, with a mean age of 50.5 years (range, 44e68
years). Half of them were menopausal, but no patient received
hormone replacement therapy. Two patients presented with
ipsilateral flank pain, while the rest were incidental findings.
The CT imaging findings revealed that all of the patients
had a contrast-enhanced renal tumor without satellite lesions
(Fig. 1). The mean tumor diameter was 4.4 cm (range,
2.2e9.0 cm). Five tumors contained cystic components, but
the proportion varied (10e80%); the other one presented as aFig. 1. Case 1: A 58-year-old woman with an epithelial and stromal tumor of
the right kidney. Enhanced computed tomography scan in the cortico-
medullary phase showed a well-demarcated, moderately-enhanced, solid,
and cystic renal mass (arrow).solid renal tumor. Only one tumor had calcification (Fig. 2).
Half of the tumors showed sinus invagination (Fig. 3). Based
on the Bosniak classification, four tumors were Bosniak
Category IV and one was Bosniak Category III (Table 1). The
mean RENAL nephrometry score was 9.3 (range, 8e11). The
clinico-radiological features of our series and other studies are
summarized in Table 1.4,12,14
The peri-operative and functional outcomes are reported in
Table 2. One patient with a tumor diameter of 9 cm underwent
open radical nephrectomy. Another underwent laparoscopic
partial nephrectomy, while four received open partial ne-
phrectomy. The mean operative time was 262.5 minutes
(range, 190e300 minutes). The mean estimated blood loss
was 118.3 mL (range, 50e200 mL), and no patient required a
blood transfusion. The mean ischemia time for the five pa-
tients who underwent partial nephrectomy was 43 minutes
(range, 23e80 min). There were neither peri-operative nor
postoperative complications. The average postoperative
follow-up without tumor recurrence was 18 months (range,
4e55 months).
All of the six tumors were benign MESTK that presented
with a variable mixture of spindle and epithelial cell compo-
nents. The spindle component varied from ovarian stroma to
scar-like fibrous tissue (Fig. 4A). The epithelial component
showed tubular, cystic, and glandular structures (Fig. 4B).
Based on the functional outcomes (Table 3), there was no
difference in the preoperative and postoperative eGFR. Simi-
larly, there was no difference in the preoperative and post-
operative split renal function in the five patients who
underwent partial nephrectomy.
4. Discussion
The main feature of MESTK is it's pathologically
biphasic structure: the epithelial and matrix components.
The epithelial component exhibits a cystic structure lined
with flat, hobnail, and cuboidal epithelium. The matrix
part surrounding the cyst is composed of spindle cells.Fig. 2. Case 2: A 46-year-old woman with an epithelial and stromal tumor of
the left kidney. Enhanced computed tomography imaging showed a solid and
cystic mass (star), with calcification near the collecting system (arrow).
Fig. 3. Case 6: A 43-year-old woman with an epithelial and stromal tumor of
the right kidney. Coronal reconstruction imaging during the postrenal phase
demonstrated a tumor with renal sinus invagination (arrow).
Fig. 4. Case 3: A 68-year-old woman with an epithelial and stromal tumor of
the right kidney. (A) Microscopically, the stromal component revealed hyali-
nizing stroma and phyllodes-like structure; (B) the epithelial component
showed numerous tubular and microcystic structures with variable linings,
including clear, oncocytic, or hobnail cells.
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to dense, the matrix part manifests as hyalinizing stroma to
ovarian-like stroma.3
The pathogenesis of MESTK remains unknown. Most cases
are benign, but malignant transformation has been reported.8
Also, most cases occur in middle-aged, peri-menopausal or
postmenopausal women.3 Some patients receive estrogen as
hormone replacement treatment,9,10 suggesting that estrogen
and the pathogenesis of MESTK may be related. Nonetheless,
some male cases of MESTK have also been reported,
including one who received estrogen therapy for underlying
prostate cancer.10 In this series, all six women were middle-
aged, but none of them had undergone estrogen therapy.
Thus, the hormone etiology hypothesis cannot explain all
cases of MESTK.
The typical clinical symptomatology of MESTK includes
hematuria, lower back pain, and a palpable mass.11 However,
recent literature and this study reveal an increasing number ofTable 1
Clinico-radiological comparison of mixed epithelial and stromal tumor of the kidn
Lane BR et al15,a Sahni VA et al5,b
Clinical features n ¼ 9 n ¼ 5
Mean age 52 55.6
Female:male 9:0 5:0
Symptomatic 6 (67%) 1 (20%)
Menopause 3 (33%) NA
Hormone replacement 2 (22%) NA
Image features
Cystic
Bosniak III 3 (30%) 3 (60%)
Bosniak IV 3 (30%) 2 (50%)
Solid 4 (40%) 0
Mean size, cm (range) 4.5 (1.7e18) 6.4 (2.6e12.4)
Calcification NA 4 (80%)
Sinus invagination 10 (100%) 2 (40%)
Nephron-sparing surgery NA 3 (60%)
Malignant transformation 1 (10%) 0
NA ¼ not applicable.
a There was one case of bilateral MEST.
b There was one case without a tumor size record.asymptomatic cases.12 The possible reason may be advances
in imaging modalities and the prevalence of health
examinations.ey series.
Chu LC et al4 Wang C et al12 Present series
n ¼ 5 n ¼ 8 n ¼ 6
58.2 38 50.5
5:0 6:2 6:0
2 (40%) 1 (13%) 2 (33%)
NA NA 3 (50%)
NA 0 0
5 (100%) NA 1 (17%)
0 NA 4 (66%)
0 NA 1 (17%)
13.3 (4e20) 4.9 (3.5e7) 4.4 (2.2e9)
2 (40%) NA 1 (17%)
5 (100%) NA 3 (50%)
1(20%) 2 (25%) 5 (83%)
0 0 0
Table 3
Evaluation of renal function in five patients who received nephron-sparing
surgery.
Preoperatively 3-mo postoperatively pa
eGFR (SD)b 89.17 (23.01) 82.83 (27.79) 0.6764
SRF% (diseased kidney)c 50.35 (5.71) 43.44 (6.93) 0.1236
eGFR ¼ estimated glomerular filtration rate; SD ¼ standard deviation;
SRF ¼ split renal function.
a Student t test.
b eGFR (mL/min/1.73 m2) ¼ 186  (Scr)1.154  (age)0.203  (0.742 if
female)  (1.212 if African-American).
c SRF (%) ¼ effective renal plasma flow of diseased kidney/total effective
renal plasma flow.
Table 2
Peri-operative profile.
Case Surgery RENAL score Estimated blood loss (mL) Ischemia time (min)a Operative time (min) Complications
1 OPN 10 180 80 295 None
2 LPN 9 180 45 280 None
3 ORN 11 200 0 300 None
4 OPN 9 50 23 270 None
5 OPN 9 50 49 190 None
6 OPN 8 50 63 240 None
LPN ¼ laparoscopic partial nephrectomy; OPN ¼ open partial nephrectomy; ORN ¼ open radical nephrectomy.
a Only one patient who received laparoscopic partial nephrectomy experienced warm ischemia for hilum control. In the remaining four open partial nephrectomy
cases cold ischemia technique was applied.
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ture often relies on CT as a diagnostic imaging tool.12,13 All
patients in Table 1 had received CT preoperatively. On CT,
MESTK appears as a multilocular cystic mass with variable
cystic components. In this series, the range of difference was
0e80%, and calcification was noted occasionally. The cases
belong to Bosniak Categories III to IV or pure solid on im-
aging. Common differential diagnoses of MESTK on CT
include cystic renal cell carcinoma and cystic nephroma.
Preoperative radiologic diagnosis of MESTK is problematic.
According to literature on the management of cystic renal
mass, Bosniak Category III lesions have 30e100% chance of
malignancy and surgery is recommended, whereas Bosniak
Category IV is deemed malignant until proven otherwise, and
surgery is strongly indicated.13,14 Also, the role of needle core
biopsy is not recommended for cystic renal masses, unless
areas with a solid pattern are present.14 Therefore, surgery is
strongly indicated in most MESTK cases.
Common differential diagnoses of MESTK on CT include
cystic renal cell carcinoma and cystic nephroma. Half of the
MESTK cases in this series revealed renal sinus invagination,
which made nephron-sparing surgery more difficult. The
anatomic features of renal tumors are evaluated using RENAL
nephrometry. The mean RENAL score in the six patients was
9.3 (range, 8e11), which means moderate-to-high complexity
of the lesions.7
Although the vast majority of MESTK cases are benign and
prognosis is good, management should follow the renal cell
carcinoma protocol.10,15 More than half of patients with
MESTK undergo radical nephrectomy.2,8,10,12 Nephron-
sparing surgery cannot be done in cases with a very largetumor size, sinus invagination, or endophytic growth. In this
series, five of the six MESTK cases had moderate-to-high
complexity and underwent partial nephrectomy. Multi-planar
reformation of the CT image improved the identification of
tumor margins and clarified the interface between the tumor
and the collecting system (Fig. 3), and was performed on four
patients to facilitate the nephron-sparing surgery. Five patients
had no peri-operative complications and no statistical differ-
ence in preoperative and postoperative split renal function
(SRF) and eGFR. There was also no tumor recurrence noted.
MESTK should be considered in middle-aged women who
may have hormone replacement history with contrast-
enhanced cystic renal tumors. Twenty percent to 60% of our
MESTK cases were managed with nephon-sparing surgery
(Table 1). In our series, only one underwent radical nephrec-
tomy for a large tumor and high RENAL score (11 points).
However, the remaining five who received partial nephrectomy
still had tumors with moderate-to-high complexity (RENAL
score 8e10 points).7 Based on the current findings, partial
nephrectomy is suitable as a treatment for MESTK, even for
difficult cases. Kamel et al16 report partial nephrectomy for
very large MESTK.
Limitations of this study are the small case number, retro-
spective design, and scarcity of MESTK cases. With advances
in imaging modalities and the rising popularity of health ex-
amination, diagnosis of asymptomatic and small MESTK will
increase. With the benign nature of MESTK and the devel-
opment of minimally invasive techniques, nephron-sparing
surgery may be the treatment of choice in the future.References
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